참고문헌
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5): 1047-1053, 2004 https://doi.org/10.2337/diacare.27.5.1047
- Rhee BD. Epidemiological characteristics of diabetes mellitus among Korean population. J Kor Diabetes Assoc 27(3): 173-178, 2003
- Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laaso M. Mortality from coronary heart disease in subjects with type 2 diabetes and without prior myocardial infarction. N Engl J Med 339(4): 229-234, 1998 https://doi.org/10.1056/NEJM199807233390404
- Lebovitz HE. Insulin resistance-a common link between type 2 diabetes and cardiovascular disease. Diabetes Obes Metab 8(3): 237-249, 2005 https://doi.org/10.1111/j.1463-1326.2005.00521.x
- Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263(1): 2893-2898, 1990 https://doi.org/10.1001/jama.263.21.2893
- Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34(6): 416-422, 1991 https://doi.org/10.1007/BF00403180
- Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 41(6): 715-722, 1992 https://doi.org/10.2337/diabetes.41.6.715
- Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 105(9): 1135-1143, 2002 https://doi.org/10.1161/hc0902.104353
- Haffner SM. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 979(2A): 3A-11A, 2006
- Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis J. Parving H. Increased urinary albumin excretion, endothelial dysfunction and chronic low-grade inflammation in type 2 diabetes; progressive, interrelated and independently associated with risk of death. Diabetes 51(4): 1157-1165, 2002 https://doi.org/10.2337/diabetes.51.4.1157
- Dandona P, Aljada A, Chaudhuri A, Mohanty P, Grag R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 111(11): 1448-1454, 2005 https://doi.org/10.1161/01.CIR.0000158483.13093.9D
- McAuley K, Mann J. Nutritional determinants of insulin resistance. J Lipid Res 47(8): 1688-1676, 2006
- Boden G, Sargrad K, Homoko C, Mozzoli M, Stein P. Effect of low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 142(6): 403-411, 2005 https://doi.org/10.1001/archinte.142.2.403
- Miyashita Y, Koide N, Ohtsuka M, Ozaki H, Itoh Y, Oyama T, Uetake T, Ariga K, Shirai K. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity. Diabetes Res Clin Pract 65(3): 234-241, 2004 https://doi.org/10.1016/j.diabres.2004.07.002
- Friedwald WT, Levy RI, Fredireck DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972
- Stoney RM, O'Dea K, Herbert KE, Dragicevict G, Giles G, Cumpston GN, Best JD. Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with type 2 diabetes mellitus. Diabet Med 18(6): 476- 482, 2001 https://doi.org/10.1046/j.1464-5491.2001.00504.x
- Matsumoto K, Kizaki Y, Fukae S, Tomihira M, Sera Y, Ueki Y, Tominaga T, Miyake S. Insulin resistance and coronary risk factors in Japanese type 2 diabetic patients with definite coronary artery disease. Diabetes Res Clin Pract 51(3): 181-186, 2001 https://doi.org/10.1016/S0168-8227(00)00199-6
- Bastard JP, Machi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17(1): 4-12, 2006
- Huh GB, Kim YL, An GJ, Jeong YS, Lee EJ, Im SG, Kim GL, Lee HY, Baeg IG, Choe MS, Lee JH. The correlation between insulin resistance and the pattern of body fat distribution in Korean patients with non-insulin dependent diabetes mellitus. Korean J Med 44(1): 1-18, 1993
- Ko KS, Rhee BD. Insulin resistance and metabolic syndrome. J Korean Diabetes Assoc 29(6): 501-506, 2005
- Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23(2): 201-229, 2002 https://doi.org/10.1210/er.23.2.201
- Festa A, Hanley AJ, Tracy RP, D'Agostino R Jr, Haffner SM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108(15): 1822-1830, 2003 https://doi.org/10.1161/01.CIR.0000091339.70120.53
- Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB. Creactive protein and incident cardiovascular events among men with diabetes. Diabetes Care 27(4): 889-894, 2004 https://doi.org/10.2337/diacare.27.4.889
- Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R. Cardiovascular Disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 28(3): 690-693, 2005 https://doi.org/10.2337/diacare.28.3.690
- Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358(9298): 2026-2033, 2001 https://doi.org/10.1016/S0140-6736(01)07098-2
- Walldius G, Jungner I. The apoB/A-1 ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J Intern Med 259(5): 493- 519, 2006 https://doi.org/10.1111/j.1365-2796.2006.01643.x
- Walldius G, Jungner I. Rationale for using apolipoprotein B and apolipoprotein A-1 as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J 26(3): 210-212, 2005 https://doi.org/10.1093/eurheartj/26.suppl_1.1
- Park YM, Sohn CM, Jang HC. Correlation of carbohydrate intake with obesity in type 2 diabetes mellitus patients. J Kor Diebetes Assoc 12(3): 254-263, 2006
- Yoon JY, Song YD, Lee JH, Park EJ, Kim SM, Lim HS, Lee HC, Huh KB. Effect of different levels of carbohydrate and fat intake on glucose and lipid metabolism in patients with NIDDM. J Kor Diebetes Assoc 19(2): 208-218, 1995
- Cho WK. Serum glucose and lipid profiles according to dietary carbohydrate and lipid intake ratio in NIDDM patients. Journal of the Korean Home Economics Association 36(11): 183-191, 1998